Drug ID: | NPD4668 |
Drug Name: | E-6201 |
Molecular Formula: | C21H27NO6 |
Canonical SMILES: | CCNc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C[C@H]([C@@H](OC(=O)c2c(c1)O)C)C |
Standard InCHI: | InChI=1S/C21H27NO6/c1-4-22-15-10-14-6-5-7-16(23)20(26)17(24)9-8-12(2)13(3)28-21(27)19(14)18(25)11-15/h5-6,8-13,16,20,22-23,25-26H,4,7H2,1-3H3/b6-5+,9-8-/t12-,13+,16+,20+/m1/s1 |
Standard InCHIKey: | MWUFVYLAWAXDHQ-HMNLTAHHSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL003524 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 10172827 |
ChEBI | |
CAS Number |
Molecular Weight | 389.18 |
ALogP | -0.7922 |
MLogP | 3 |
XLogP | 2.754 |
HDA | 6 |
HBD | 4 |
Rotatable Bonds | 8 |
TPSA | 116.09 |
RO5 Violation | 0 |